Ventilation in extremely preterm infants and respiratory function at 8 years

New England Journal of Medicine

Volumn 377, Issue 4, 2017, Pages 329-337

  Doyle, Lex W ^a,b,c,d   Carse, Elizabeth ^f   Adams, Anne Marie ^e,g   Ranganathan, Sarath ^e,g   Opie, Gillian ^h   Cheong, Jeanie L Y ^a,b,d  

^a ROYAL WOMEN'S HOSPITAL   (Australia)

^b Obstetrics and Gynaecology   (Australia)

^c Paediatric Unit   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e Infection and Immunity   (Australia)

^f MONASH MEDICAL CENTRE   (Australia)

^g ROYAL CHILDREN'S HOSPITAL   (Australia)

^h MERCY HOSPITAL FOR WOMEN   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

SURFACTANT; GLUCOCORTICOID;

AIRWAY OBSTRUCTION; ARTICLE; ARTIFICIAL VENTILATION; ASSISTED VENTILATION; AUSTRALIA; CHILD; COMPARATIVE STUDY; ENDOTRACHEAL VENTILATION; ETHNIC DIFFERENCE; EXPIRATORY AIRFLOW; EXTREMELY PRETERM INFANT; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GESTATIONAL AGE; HUMAN; LONGITUDINAL STUDY; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; NASAL CONTINUOUS POSITIVE AIRWAY PRESSURE; NEWBORN INTENSIVE CARE; OUTCOME ASSESSMENT; OXYGEN DEPENDENCE; OXYGEN THERAPY; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY FUNCTION; RESPIRATORY TRACT PARAMETERS; SCHOOL CHILD; SURVIVAL RATE; SURVIVAL TIME; TIME SERIES ANALYSIS; TREATMENT DURATION; WHEEZING; BRONCHOPULMONARY DYSPLASIA; HIGH FREQUENCY VENTILATION; INTERMITTENT POSITIVE PRESSURE VENTILATION; NEWBORN; RESPIRATORY DISTRESS SYNDROME, NEWBORN; TIME FACTOR; UTILIZATION; VITAL CAPACITY;

BRONCHOPULMONARY DYSPLASIA; CHILD; CONTINUOUS POSITIVE AIRWAY PRESSURE; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; GLUCOCORTICOIDS; HIGH-FREQUENCY VENTILATION; HUMANS; INFANT, EXTREMELY PREMATURE; INFANT, NEWBORN; INTERMITTENT POSITIVE-PRESSURE VENTILATION; MALE; OXYGEN INHALATION THERAPY; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, NEWBORN; SURVIVAL RATE; TIME FACTORS; VITAL CAPACITY;

EID: 85026216509     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1700827     Document Type: Article

References (21)

1. Jobe AH, Bancalari E. Bronchopulmo-nary dysplasia. Am J Respir Crit Care Med 2001;163:1723-9.
2. Reynolds EO. Management of hyaline membrane disease. Br Med Bull 1975;31: 18-24.
3. Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006; 3:CD004454.
4. Soll RF. Surfactant treatment of the very preterm infant. Biol Neonate 1998; 74:Suppl 1:35-42.
5. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005;26:319-38.
6. Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the Global Lung Function 2012 equations. Eur Respir J 2012;40:1324-43.
7. Doyle LW, Anderson P, Callanan C, et al. Respiratory function at age 8-9 years in extremely low birthweight/very preterm children born in Victoria in 1991–1992. Pediatr Pulmonol 2006;41:570-6.
8. Hacking DF, Gibson AM, Robertson C, Doyle LW. Respiratory function at age 8-9 after extremely low birthweight or preterm birth in Victoria in 1997. Pediatr Pulmonol 2013;48:449-55.
9. Asher MI, Keil U, Anderson HR, et al. International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J 1995;8:483-91.
10. Cheong JLY, Anderson PJ, Burnett AC, et al. Changing neurodevelopment at 8 years of children born extremely preterm since the early 1990s. Pediatrics 2017;139: e20164086.
11. Gibson AM, Doyle LW. Respiratory outcomes for the tiniest or most immature infants. Semin Fetal Neonatal Med 2014;19:105-11.
12. Vollsæter M, Skromme K, Satrell E, et al. Children born preterm at the turn of the millennium had better lung function than children born similarly preterm in the early 1990s. PLoS One 2015;10(12): e0144243.
13. Doyle LW, Ehrenkranz RA, Halliday HL. Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev 2014;5:CD001146.
14. Doyle LW, Ehrenkranz RA, Halliday HL. Late (> 7 days) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database Syst Rev 2014;5:CD001145.
15. Doyle LW, Halliday HL, Ehrenkranz RA, Davis PG, Sinclair JC. An update on the impact of postnatal systemic corticosteroids on mortality and cerebral palsy in preterm infants: effect modification by risk of bronchopulmonary dysplasia. J Pediatr 2014;165:1258-60.
16. Manley BJ, Owen LS, Doyle LW, et al. High-flow nasal cannulae in very preterm infants after extubation. N Engl J Med 2013;369:1425-33.
17. Kirpalani H, Millar D, Lemyre B, Yo-der BA, Chiu A, Roberts RS. A trial comparing noninvasive ventilation strategies in preterm infants. N Engl J Med 2013; 369:611-20.
18. Roberts CT, Owen LS, Manley BJ, et al. Nasal high-flow therapy for primary respiratory support in preterm infants. N Engl J Med 2016;375:1142-51.
19. Thomas MR, Rafferty GF, Limb ES, et al. Pulmonary function at follow-up of very preterm infants from the United Kingdom Oscillation Study. Am J Respir Crit Care Med 2004;169:868-72.
20. Zivanovic S, Peacock J, Alcazar-Paris M, et al. Late outcomes of a randomized trial of high-frequency oscillation in neonates. N Engl J Med 2014;370:1121-30.
21. Doyle LW, Adams AM, Robertson C, et al. Increasing airway obstruction from 8 to 18 years in extremely preterm/low-birthweight survivors born in the surfactant era. Thorax 2016 September 6 (Epub ahead of print).